1. ScholarBank@NUS

Wan-Teck Darren Lim

rp07954

Collaboration Map View Statistics Email Alert RSS Feed

Profile

Full Name
Wan-Teck Darren Lim
Variants
Lim, W.-T.
 
Main Affiliation
 
Faculty
 
Email
gmslwtd@nus.edu.sg
 

Publications

Refined By:
Department:  DEAN'S OFFICE (DUKE-NUS MEDICAL SCHOOL)
Policy:  Open
Department:  DUKE-NUS OFFICE OF ACAD & CLINICAL DEVT

Results 1-7 of 7 (Search time: 1.075 seconds).

Issue DateTitleAuthor(s)
12019Association of clinical factors with survival outcomes in laryngeal squamous cell carcinoma (LSCC).Fong, Pei Yuan; Tan, Sze Huey ; Lim, Darren Wan Teck ; Tan, Eng Huat ; Ng, Quan Sing ; Sommat, Kiattisa ; Tan, Daniel Shao Weng ; Ang, Mei Kim 
21-Sep-2021Dysfunctional bronchial cilia are a feature of Chronic Obstructive Pulmonary Disease (COPD)Biju Thomas ; Mariko Siyue Koh ; Chris O'Callaghan; JOHN ALLEN ; Andrew Rutman; Rob Hirst; John Connolly ; Su Ying Low ; Ong Thun How ; Loo Chian Min ; Darren Wan Teck Lim ; Oon Lin Ean Lynette ; Qixian He; Oon Hoe Teoh ; Therese Lapperre 
32015Impact of smoking and brain metastasis on outcomes of advanced EGFR mutation lung adenocarcinoma patients treated with first line epidermal growth factor receptor tyrosine kinase inhibitorsJain A.; Lim C. ; Gan E.M.; Ng D.Z.; Ng Q.S.; Ang M.K. ; Takano A. ; Chan K.S. ; Tan W.M.; Kanesvaran R. ; Toh C.K. ; Loo C.M. ; Hsu A.A.L. ; Devanand A. ; Lim C.H. ; Koong H.N. ; Koh T. ; Fong K.W. ; Yap S.P.; Kim S.W.; Chowbay B. ; Oon L. ; Lim K.H. ; Lim W.T. ; Tan E.H. ; Tan D.S.W. 
43-Dec-2018Influence of afatinib dose on outcomes of advanced EGFR-mutant NSCLC patients with brain metastasesTan, Wan-Ling ; Ng, Quan Sing ; Lim, Cindy; Tan, Eng Huat ; Toh, Chee Keong; Ang, Mei-Kim ; Kanesvaran, Ravindran ; Jain, Amit ; Tan, Daniel SW ; Lim, Darren Wan-Teck 
524-Dec-2018Influence of afatinib dose on outcomes of advanced EGFR-mutant NSCLC patients with brain metastases (vol 18, 1198, 2018)Tan, Wan-Ling ; Ng, Quan Sing ; Lim, Cindy; Tan, Eng Huat ; Toh, Chee Keong; Ang, Mei-Kim ; Kanesvaran, Ravindran ; Jain, Amit ; Tan, Daniel SW ; Lim, Darren Wan-Teck 
61-Jun-2018Phase 1b Trial of Ficlatuzumab, a Humanized Hepatocyte Growth Factor Inhibitory Monoclonal Antibody, in Combination With Gefitinib in Asian Patients With NSCLCTan, Eng-Huat ; Lim, Wan-Teck ; Ahn, Myung-Ju; Ng, Quan-Sing ; Ahn, Jin Seok; Tan, Daniel Shao-Weng ; Sun, Jong-Mu; Han, May; Payumo, Francis C; Mckee, Krista; Yin, Wei; Credi, Marc; Agarwal, Shefali; Jac, Jaroslaw; Park, Keunchil
72016Phase I study of oral vinorelbine in combination with erlotinib in advanced non-small cell lung cancer (NSCLC) using two different schedulesSutiman N.; Zhang Z.; Ang M.K. ; Tan S.-W.D.; Toh C.K.; Ng Q.S.; Chowbay B. ; Lim W.-T.